Phase II trial of idarubicin (4-demethoxydaunorubicin) in advanced breast cancer
- 1 March 1989
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 25 (3), 423-428
- https://doi.org/10.1016/0277-5379(89)90254-x
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- New anthracycline analogs in advanced breast cancerEuropean Journal of Cancer and Clinical Oncology, 1986
- Phase II trial with oral idarubicin in advanced breast cancerInvestigational New Drugs, 1986
- Disposition and metabolism of [14-14C] 4-demethoxydaunorubicin HCl (idarubicin) and [14-14C]daunorubicin HCl in the ratCancer Chemotherapy and Pharmacology, 1986
- Phase-II Trial of Oral Idarubicin (4-Demethoxydaunorubicin) in Advanced Breast CancerOncology Research and Treatment, 1986
- Activity of 4-demethoxydaunorubicin by the oral route in advanced breast cancerEuropean Journal of Cancer and Clinical Oncology, 1985
- Phase I trial of 4-demethoxydaunorubicin (idarubicin) with single oral dosesInvestigational New Drugs, 1984
- Phase I study of 4-demethoxydaunorubicinInvestigational New Drugs, 1983
- PHASE-I AND CLINICAL-PHARMACOLOGY STUDIES OF INTRAVENOUS AND ORAL-ADMINISTRATION OF 4-DEMETHOXYDAUNORUBICIN IN PATIENTS WITH ADVANCED CANCER1983
- Reporting results of cancer treatmentCancer, 1981
- SYNTHESIS AND ANTITUMOR ACTIVITY OF 4-DEMETHOXYDAUNORUBICIN, 4-DEMETHOXY-7,9-DIEPIDAUNORUBICIN, AND THEIR BETA-ANOMERS1976